Wird geladen...
Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors
Early stage nonseminomatous germ cell tumor (NSGCT) remains a treatable disease, with stage I cancer specific survival exceeding 95%. Using a risk-adapted approach; active surveillance (AS), adjuvant chemotherapy, and retroperitoneal lymph node dissection (RPLND) all options for treatment; with surv...
Gespeichert in:
| Veröffentlicht in: | Transl Androl Urol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995850/ https://ncbi.nlm.nih.gov/pubmed/32055485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2019.05.14 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|